TABLE 2

Uptake and metabolism kinetic parameters of repaglinide estimated in three human hepatocyte donors using an extended mechanistic two-compartment model

Uptake kinetics was measured in cryopreserved human hepatocytes plated for 6 h at seven concentrations (0.1–300 μM) in the presence (HU4122) or absence (HU4199 and HU8089) of 1 mM ABT.

DonorHU4122HU4199HU8089Mean
Km, u, μM15.68.9713.812.8 ± 3.4
Vmax, pmol · min−1 · 106 cells−11236310464670 ± 496
Pdiff, u, μl · min−1 · 106 cells−110.016.012.012.7 ± 3.1
fucella0.0740.0740.0740.074
fumed0.950.940.960.95 ± 0.01
CLactive, u, μl · min−1 · 106 cells−179.034.633.649.1 ± 25.9
CLmet, gluc, u, μl · min−1 · 106 cells−10.4120.2420.327
Km, M2, u, μM41.57.4024.4
CLmet, M2, u, μl · min−1 · 106 cells−10.9502.421.68
Km, M4, u, μM5.328.837.07
CLmet, M4, u, μl · min−1 · 106 cells−10.6191.290.957
CLmet,t otal, u, μl · min−1 · 106 cells−11.983.962.97
  • a Data from uptake experiments performed in rat hepatocytes over an extended incubation time (Ménochet et al., 2012).